Tethis S.p.A

A fantastic opportunity to join the Tethis team and contribute to the development of our innovative cytology-based liquid biopsy diagnostic test!

We are hiring! We are looking for an R&D Laboratory Technician   Main activities: - Sampling, preparation and staining of biological samples - Human cell cultures - Use of bright field and fluorescence microscopy - Management and maintenance of laboratory equipment - Data reporting Requirements: - Bachelor's degree or equivalent diploma in Scientific subjects, preferably in Biology - Experience of at least 2 years in a biomedical laboratory - Good knowledge of the main techniques for preparing biological samples - Accuracy, reliability and precision - Ability to work in a young and dynamic team environment - Willingness to learn at work and break new grounds is essential If you are interested please send your cv at: contact@tethis-lab.com

We are hiring! We are looking for an R&D Laboratory Technician   Main activities: - Sampling, preparation and staining of biological samples - Human cell cultures - Use of bright field and fluorescence microscopy - Management and maintenance of laboratory equipment - Data reporting Requirements: - Bachelor's degree or equivalent diploma in Scientific subjects, preferably in Biology - Experience of at least 2 years in a biomedical laboratory - Good knowledge of the main techniques for preparing biological samples - Accuracy, reliability and precision - Ability to work in a young and dynamic team environment - Willingness to learn at work and break new grounds is essential If you are interested please send your cv at: contact@tethis-lab.com

Want to revolutionize immune and tumor cell identification on cytology slides? Don't miss the poster presentation by Laurent Gole, our R&D Imaging Unit Manager, at the 8th Digital Pathology & AI Congress in Singapore, September 10-11 (https://lnkd.in/dQWFMUAk). Discover how we automatically transform blood draws into cytology slides optimized for AI-driven digital analysis.  

Want to revolutionize immune and tumor cell identification on cytology slides? Don't miss the poster presentation by Laurent Gole, our R&D Imaging Unit Manager, at the 8th Digital Pathology & AI Congress in Singapore, September 10-11 (https://lnkd.in/dQWFMUAk). Discover how we automatically transform blood draws into cytology slides optimized for AI-driven digital analysis.  

Want to innovate/revolutionize your approaches in pathology? Discover how to: - Effortlessly fix non-adherent cells on microscopy slides; - Standardize pre-analytics in liquid biopsy; - Automatically transform blood draws into cytology slides to characterize immune and tumor cells. Meet Roberta Carbone, our Chief Scientific Officer, at the 36th European Congress of Pathology (https://lnkd.in/dai6p9R) in Florence, Italy in the next few days.  

Want to innovate/revolutionize your approaches in pathology? Discover how to: - Effortlessly fix non-adherent cells on microscopy slides; - Standardize pre-analytics in liquid biopsy; - Automatically transform blood draws into cytology slides to characterize immune and tumor cells. Meet Roberta Carbone, our Chief Scientific Officer, at the 36th European Congress of Pathology (https://lnkd.in/dai6p9R) in Florence, Italy in the next few days.  

We are excited to announce Tethis collaboration with Weill Cornell Medicine to test Tethis’ instruments for monitoring the response to curative treatment in patients with early-stage breast cancer. The scientists will collect blood from the patients and will measure the number and kind of tumor cells (cellular residual disease) and DNA (molecular residual disease) released from the tumor in the blood. Thanks to everyone involved in making this collaboration possible! Alyssa Sunkin-Strube Massimo Cristofanilli, MD, FACP Carolina Reduzzi Olivier Elemento Holger Neecke, PhD, MBA Roberta Carbone Sabrina Picocci Center for Technology Licensing at Cornell University (CTL) https://lnkd.in/dj55MjJC

We are excited to announce Tethis collaboration with Weill Cornell Medicine to test Tethis’ instruments for monitoring the response to curative treatment in patients with early-stage breast cancer. The scientists will collect blood from the patients and will measure the number and kind of tumor cells (cellular residual disease) and DNA (molecular residual disease) released from the tumor in the blood. Thanks to everyone involved in making this collaboration possible! Alyssa Sunkin-Strube Massimo Cristofanilli, MD, FACP Carolina Reduzzi Olivier Elemento Holger Neecke, PhD, MBA Roberta Carbone Sabrina Picocci Center for Technology Licensing at Cornell University (CTL) https://lnkd.in/dj55MjJC

We are excited to share that the collaborative efforts of the Università degli Studi di Bari, CNR Bari, KU Leuven, and Tethis S.p.A have resulted in the development of a new method for isolating and characterizing single circulating tumor cells (CTCs) from the blood of cancer patients. This innovative method, published in PlosONE (https://lnkd.in/dd94sq-z), utilizes Tethis nanocoated Smart BioSurface slides, laser capture microdissection, and subsequent whole genome amplification, offering promising applications in the field of cancer research and treatment.  Watch the interview (https://lnkd.in/d3UgEP9K) featuring Prof. Clelia Tiziana Storlazzi and Dr. Roberta Carbone providing a detailed description of the protocol for this single cell-based approach, further highlighting the significance of this research in advancing our understanding of CTCs. Grazia Visci Doron Tolomeo Lorenzo Bascetta Margot van Riel Aram Arshadi Gianluca Trotta STIIMA-CNR Joris Vermeesch KU Leuven